Pluribus Labs’s MasTec MTZ Stock Holding History

Pluribus Labs’s Portfolio MTZ Stock Details MTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,539	Closed	-$788K	–	168
2021 Q4	$788K	Buy	+8,539	New	+$780K	0.83%	13

Other funds holding MTZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Legacy Advisors Plymouth Meeting, Pennsylvania $848M AUM 21.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Pluribus Labs's MTZ Position: Q1 2022 in Review

Pluribus Labs sold out of MasTec (MTZ) in Q1 2022, closing a stake of 8,539 shares — an estimated $788K sold.

Pluribus Labs first reported a position in MTZ in Q4 2021 and held it in 1 quarter. The position peaked at $788K in Q4 2021. 387 funds tracked by Wall St. Rank hold MTZ as of Q1 2022.

Pluribus Labs reported no remaining MasTec position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 8,539 MasTec shares in Q1 2022, an estimated $788K.
Pluribus Labs first reported a position in MasTec in Q4 2021 and held it in 1 quarter.
Pluribus Labs's MasTec position peaked at $788K in Q4 2021.
387 funds tracked by Wall St. Rank held MasTec as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.